https://cleantechnica.com/2023/01/11/you-cant-order-a-ford-f-150-lightning-any-longer-count-this-as-a-fail/
Purple Biotech’s Assets Are First In Class For Solid Tumor Treatment, Analyst Says
HC Wainwright initiated coverage on Purple Biotech (NASDAQ:PPBT) with a Buy rating and a price target of $7. The company is working…